
Perospirone
CAS No. 150915-41-6
Perospirone( —— )
Catalog No. M18058 CAS No. 150915-41-6
Perospirone is an antagonist of serotonin 5HT2A receptors and dopamine D2 receptors. It also displays affinity towards 5HT1A receptors as a partial agonist.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 55 | In Stock |
![]() ![]() |
10MG | 91 | In Stock |
![]() ![]() |
25MG | 171 | In Stock |
![]() ![]() |
50MG | 309 | In Stock |
![]() ![]() |
100MG | 528 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NamePerospirone
-
NoteResearch use only, not for human use.
-
Brief DescriptionPerospirone is an antagonist of serotonin 5HT2A receptors and dopamine D2 receptors. It also displays affinity towards 5HT1A receptors as a partial agonist.
-
DescriptionPerospirone is an antagonist of serotonin 5HT2A receptors and dopamine D2 receptors. It also displays affinity towards 5HT1A receptors as a partial agonist.
-
In Vitro——
-
In VivoAnimal Model:Male ICR mice (6 weeks old) weighing 25-30 g Dosage:1.0, 3.0 or 10.0 mg/kg Administration:Orally; daily; for 14 consecutive days Result:Significantly attenuated PCP-induced cognitive deficits in mice in a dose-dependent manner.
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetPARP
-
Recptor5-HT2A|D2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number150915-41-6
-
Formula Weight426.57
-
Molecular FormulaC23H30N4O2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 5 mg/mL (11.72 mM)
-
SMILESO=C1[C@H]2CCCC[C@H]2C(=O)N1CCCCN1CCN(CC1)c1nsc2ccccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference



-
ARTD10/PARP10-IN-1
ARTD10/PARP10-IN-1 is a potent PARP inhibitor of the mono-ADP ribosyltransferases ARTD7/PARP15, ARTD8/PARP14, ARTD10/PARP10 and poly ADP-ribose polymerase-1 (ARTD1/PARP1), with potential anticancer and antitumour activity for the study of prostate and breast cancers.
-
Rucaparib Camsylate
Rucaparib Camsylate is a PARP inhibitor (PARP1,Ki of 1.4 nM). Rucaparib Camsylate also displays binding affinity to eight other PARP domains. Rucaparib is the most effective PARP inhibitor in enzyme assays (Ki: 1.4 nM). Rucaparib inhibits PARP-1 activity by 97.1% at a concentration of 1 μM in permeabilized D283Med cells.
-
UNBS-5162
UNBS-5162 is a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers.